Travere Therapeutics shares owned by Caas Capital Management
Quarter-by-quarter ownership of Travere Therapeutics shares owned by Caas Capital Management
from 13F filings
Historical chart of Caas Capital Management investment in Travere Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Travere Therapeutics held by Caas Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Travere Therapeutics by Caas Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $317k | 500k | 0.63 |
| 2023-06-30 | $407k | 500k | 0.81 |
| 2023-03-31 | $491k | 500k | 0.98 |
| 2022-12-31 | $454k | 500k | 0.91 |
| 2022-09-30 | $508k | 500k | 1.02 |
| 2022-06-30 | $501k | 500k | 1.00 |
| 2022-03-31 | $527k | 500k | 1.05 |